INTRODUCTION
Ca2l-mobilizing agonists such as phenylephrine and vasopressin, which are mediated by Ins(1,4,5)P3, induce oscillations in cytoplasmic concentration of free Ca2+ ('free Ca') in single rat hepatocytes [1, 2] . Although the frequency of the oscillations depends on agonist dose, the time course of an individual spike does not change with agonist concentration. A spike's time course does, however, depend on the agonist species. Although the rise time and amplitude do not change with the agonist, the falling time, and hence the spike duration, is markedly dependent on the type of the agonist, in the same individual hepatocyte [1] [2] [3] [4] [5] . This agonist-specificity in the oscillator mechanisms has yet to be explained.
Studies with permeabilized hepatocytes have shown that a maximal dose of Ins (1, 4, 5) P3 releases only a part of the Ca2+ stored in the non-mitochondrial pool: the residual Ca2+ can be released by Ca2+ ionophores [6, 7] . These data suggest that the Ins(1,4,5)P3-insensitive pool is a separate membrane-limited compartment. Ryanodine, a plant alkaloid which locks the sarcoplasmic-reticulum Ca2+ channel in the open state [8] [9] [10] , blocks Ins(1,4,5)P3-independent free Ca oscillations in several cell types [11, 12] ; thus blockade by ryanodine provides evidence for a Ca2+-induced Ca2+ release (CICR) mechanism [11, 13] . Recently high-affinity ryanodine-binding sites have been found in rat liver microsomes [14] . The ryanodine-binding sites were distinct from Ins(1,4,5)PJ?-binding sites and had different distributions between the various sub-microsomal fractions [15] .
Here we show that ryanodine fails to modify phenylephrineinduced spikes (as previously described in outline [5] ), but does inhibit spikes induced by vasopressin or angiotensin II. Furthermore, ryanodine can truncate the falling phase of vasopressin-or angiotensin II-induced spikes prolonged by elevated cyclic AMP [16] . We propose that vasopressin-or angiotensinangiotensin II-induced spikes. We also show that ryanodine has no effect either on the increase in frequency or on the elevated peak free Ca induced by increased cyclic AMP on phenylephrine spikes. In contrast, ryanodine truncates the prolonged falling phases of spikes induced by vasopressin or angiotensin II in the presence of elevated cyclic AMP. A working hypothesis is proposed in which vasopressin-or angiotensin II-induced spikes consist of an Ins(1,4,5)P3-Mediated symmetrical spike, identical in time course and mechanism with those induced by phenylephrine, followed by a 'tail' that represents CICR. The data hint at the existence of a novel signalling pathway.
induced spikes consist of an Ins(1,4,5)P3-mediated symmetrical spike, similar in time course and mechanism to those induced by phenylephrine, followed by a 'tail' that represents CICR. These data raise the question why ryanodine-sensitivity should occur only in vasopressin-or angiotensin-treated cells, and why the Ins(1,4,5)PJ-mediated component of the spikes induced by these peptides is abolished by ryanodine.
MATERIALS AND METHODS
Single hepatocytes from fed male Wistar-strain rats (180-250 g) were isolated and injected with the photoprotein aequorin as described previously [17] , and the free Ca changes were recorded by photomultiplier. The experimental medium was William's Medium E (Flow Laboratories) gassed with C02/air (1: 19) at 37 'C. All substances were added to this medium. Phenylephrine, vasopressin, angiotensin II and dibutyryl cyclic AMP were from Sigma, and ryanodine was from Calbiochem.
RESULTS
We carried out experiments using ryanodine, a well-known blocker of the CICR mechanism in those cell types where this mechanism is responsible for generating free Ca oscillations [13] .
Figure 1(a) shows that ryanodine (1, 10 or 100 lM) did not produce any significant change on phenylephrine-induced spikes over periods of exposure of 10-60 min (seven out of ten hepatocytes). Similar absence of effect of ryanodine on phenylephrineinduced spikes has been found in single hepatocytes loaded with Fura-2 [18] . In hepatocytes 8 and 9, a slight decrease in phenylephrine-induced spiking frequency was found at ryanodine concentrations of 10 cyte to 100 ,uM ryanodine for 20 min had no effect on free Ca, nor did it have any effect on subsequent phenylephrine-induced spikes (results not shown).
The effect of ryanodine on vasopressin-induced spiking is markedly different. Figure 2 (a) shows that 10 uM ryanodine promptly and irreversibly blocked vasopressin spikes. This result was found in seven out of 14 hepatocytes stimulated with vasopressin and treated with ryanodine at concentrations from 1 to 30 ,uM. In five of the remaining seven hepatocytes, ryanodine, in the same concentration range, irreversibly decreased the frequency of vasopressin-induced spikes (results not shown). In hepatocyte 13, ryanodine did not produce any significant change in vasopressin-induced free Ca oscillations, even at concentrations of 50 ,tM (results not shown), and in hepatocyte 14, 10 uM ryanodine decreased the peak free Ca of oscillations induced by vasopressin (results not shown).
Figure 2(b) shows that ryanodine irreversibly decreased the frequency and slightly decreased the peak free Ca of spikes induced by 0.5 nM angiotensin II. This effect was ryanodinedose-dependent and was found in three out of five hepatocytes stimulated with angiotensin II and treated with ryanodine. In one ofthese three hepatocytes, ryanodine decreased the frequency of angiotensin 1I-induced spikes without any effect on peak free Ca (results not shown). In the fourth and fifth hepatocytes, ryanodine (1-5 1tM) irreversibly stopped the spikes induced by angiotensin II (results not shown) in a manner resembling that shown in Figure 2 (a).
Dibutyryl cyclic AMP increases the frequency and peak free Ca of spikes induced by phenylephrine [16] . Figure 3(a) shows this response and also shows that ryanodine has no significant effect on either frequency or peak free Ca of spikes induced by phenylephrine and elevated cyclic AMP (five hepatocytes). Low concentrations of cyclic AMP prolong the falling phase of vasopressin-induced spikes [16] . Figure 3(b) shows that 2,tM ryanodine shortened the falling phase of the prolonged spikes In (a), ryanodine (50 ,M) subsequently has no effect. In (b), ryanodine (2 MM) promptly truncated the tails, particularly for the first two or three spikes.
phenylephrine. So ryanodine (10 lM) affects neither agonist binding nor, probably, interaction of these receptors with their G-protein(s). Evidence is emerging that these two receptors may communicate with a common pool of G-proteins [20] , and it is therefore unlikely that the different ryanodine sensitivity of vasopressin and phenylephrine Ca spiking arises before InsP3 generation.
DISCUSSION
The evidence suggests that CICR mediated by a muscle-like ryanodine receptor plays no role in hepatocyte Ca oscillations induced by phenylephrine. Ryanodine almost certainly enters hepatocytes rapidly; its rapid blockade of Ca oscillations in myocytes [5] , and prompt effects on vasopressin-induced spiking (Figures 2 and 3 ) both point to rapid ryanodine entry into cells. So the lack of effect of ryanodine on phenylephrine-induced spiking (Figure 1 ; [5, 18] ) almost certainly reflects a lack of importance of CICR mediated by the ryanodine receptor in phenylephrine-induced spiking. Hepatocytes do show intracellular, high-affinity and specific ryanodine-binding sites [14] , which appear to be predominantly in a different microsomal fraction from that enriched with InsPt-binding sites [15] . So, presumably, in phenylephrine-stimulated cells either the ryanodine receptors are somehow inactivated, or their compartment has insufficient luminal Ca2l to permit CICR. We conclude, as have others [18] , that CICR mediated by the ryanodine receptor plays no role in phenylephrine-induced Ca2+ oscillations in hepatocytes. The question of how Ca21 waves propagate across a hepatocyte, which has previously been attributed to a wave of CICR traversing the cell, initiated by a focal rise in free Ca induced by local InsP3 generation [21] , needs to be reconsidered. The most likely mechanism for generating phenylephrine-induced Ca2+ spikes in hepatocytes resides in the lnsI3 pathway, either by pulsatile generation of InsP3, as we have previously favoured [2] [3] [4] [5] , or by complex dynamic behaviour of the InsP3 receptor that we have outlined in the preceding paper [16] . In the latter model free Ca can promote, and then suppress, InsP3-receptor action; conceivably this feedback of free Ca on to the InsPJ receptor could be responsible for Ca2+ waves, provided that the InsP3 is generated globally, not locally. Thus CICR mediated by the InsP3 receptor, rather than the ryanodine receptor, probably accounts for the phenylephrine-induced spikes.
If we accept that phenylephrine generates spikes solely by an InsP3-mediated mechanism, the problem then arises of why ryanodine abolishes vasopressin-induced or angiotensin IIinduced hepatocyte free Ca oscillations (Figures 2 and 3b Unfortunately detailed information on the characteristics of the liver ryanodine receptor is, as yet, sparse. In other nonmuscle cells, ryanodine receptors have been shown to differ from that in muscle by being insensitive to caffeine and Ruthenium Red, or even to ryanodine. In liver, Shoshan-Barmatz et al. [15] show ryanodine binding to be Ca2l-insensitive, from which one would predict that the liver ryanodine receptor may not be capable of generating CICR. We can therefore only speculate on the possible mechanism of action of vasopressin-induced Ca2" spiking. Differential localization of ryanodine and InsP3 receptors has been observed [15] , and the concept of there being discrete InsP3-sensitive and -insensitive Ca2+ pools is widely recognized [22, 23] . If a putative ryanodine-receptor-rich compartment, devoid ofinsP receptors, became Ca2+-loaded only in the presence of vasopressin, some of the effects of ryanodine described here would be explained. But, unless the ryanodine-receptor-rich pool were somehow to deplete the InsP3-receptor-rich compartment of (a) 1 Whatever the nature of an additional second messenger involved in vasopressin signalling, it is clear that it has no effect on the rising phase of the spikes nor on Ca2+-wave propagation; this phase of the oscillator is probably solely the role of InsP, action. The putative second messenger would only be active during the falling phase of the spikes. Indeed, its action may be triggered by the rise in free Ca induced by InsP3 action. So a novel Ca2+-mobilizing second messenger acting independently of InsP3, for which cyclic ADP-ribose might provide a model [24] , would be unlikely to explain our data. The effects of elevated cyclic AMP on spikes induced by phenylephrine and vasopressin are different [16] , with prolonged falling phases appearing in the presence of vasopressin. The ability of ryanodine promptly to truncate their prolonged tails (Figure 3b) suggests some involvement of ryanodine receptors. These conditions, using either phenylephrine or vasopressin in the presence of elevated cyclic AMP, could be particularly useful in the search for the putative novel second messenger involved in this agonist-specific sensitivity of the hepatocyte Ca21 oscillator to ryanodine.
